Pharmerica Corporation (NYSE:PMC) has earned an average recommendation of “Hold” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $29.25.

Several brokerages recently issued reports on PMC. Barrington Research downgraded shares of Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a research report on Wednesday, August 9th. KeyCorp downgraded shares of Pharmerica Corporation to an “overweight” rating in a research report on Tuesday, August 8th. Credit Suisse Group downgraded shares of Pharmerica Corporation from an “outperform” rating to a “neutral” rating and upped their price target for the stock from $29.00 to $29.25 in a research report on Friday, August 4th. They noted that the move was a valuation call. UBS AG reiterated a “neutral” rating and set a $29.25 price target (up previously from $26.00) on shares of Pharmerica Corporation in a research report on Thursday, August 3rd. Finally, BidaskClub downgraded shares of Pharmerica Corporation from a “hold” rating to a “sell” rating in a research report on Monday, July 31st.

A number of hedge funds and other institutional investors have recently modified their holdings of PMC. Phocas Financial Corp. increased its position in shares of Pharmerica Corporation by 4.7% in the second quarter. Phocas Financial Corp. now owns 273,788 shares of the company’s stock valued at $7,187,000 after buying an additional 12,214 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in Pharmerica Corporation during the second quarter worth about $200,000. Public Employees Retirement System of Ohio increased its position in Pharmerica Corporation by 10.5% in the second quarter. Public Employees Retirement System of Ohio now owns 5,028 shares of the company’s stock worth $132,000 after buying an additional 476 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Pharmerica Corporation by 0.3% in the second quarter. The Manufacturers Life Insurance Company now owns 23,228 shares of the company’s stock worth $610,000 after buying an additional 71 shares during the last quarter. Finally, State Street Corp increased its position in Pharmerica Corporation by 1.6% in the second quarter. State Street Corp now owns 808,831 shares of the company’s stock worth $21,236,000 after buying an additional 12,607 shares during the last quarter. Institutional investors and hedge funds own 92.35% of the company’s stock.

Shares of Pharmerica Corporation (PMC) traded down 0.17% during mid-day trading on Monday, reaching $29.15. 431,472 shares of the company traded hands. The stock has a market capitalization of $907.18 million, a PE ratio of 39.50 and a beta of 0.92. The stock’s 50 day moving average is $27.40 and its 200 day moving average is $25.23. Pharmerica Corporation has a 52-week low of $19.20 and a 52-week high of $29.20.

Pharmerica Corporation (NYSE:PMC) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $0.47 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.47. The business had revenue of $592 million for the quarter, compared to the consensus estimate of $592.96 million. Pharmerica Corporation had a net margin of 1.05% and a return on equity of 10.94%. The firm’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.47 EPS. On average, analysts anticipate that Pharmerica Corporation will post $1.92 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/analysts-set-pharmerica-corporation-pmc-pt-at-29-25/1534655.html.

Pharmerica Corporation Company Profile

Receive News & Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.